Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence

These data indicate that low expression of LMNA is associated with an increased disease recurrence in stage II and III colon cancer patients, and suggest that these patients in particular may benefit from adjuvant chemotherapy.